Načítá se...
Vav1 mutations identified in human cancers give rise to different oncogenic phenotypes
Vav1 is physiologically active as a GDP/GTP nucleotide exchange factor (GEF) in the hematopoietic system. Overexpression of Vav1 in multiple tumor types is known to enhance oncogenicity, yet whether or not Vav1 is a bona fide oncogene is still a matter of debate. Although mutations in Vav1 were rece...
Uloženo v:
| Vydáno v: | Oncogenesis |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Nature Publishing Group UK
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6175932/ https://ncbi.nlm.nih.gov/pubmed/30297765 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41389-018-0091-1 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|